ABSTRACT The transfer of the vesicular stomatitis virus-encoded glycoprotein (G protein) between Golgi populations in fused cells (Rothman, J . E., L. J . Urbani, and R . Brands . 1984 . 
The Golgi complex occupies a central position in the pathway of intracellular protein transport. A mixture of proteins exported from the endoplasmic reticulum seems to enter the Golgi stack at one end (the cis face) and to exit from the stack at the other (the trans face) after having been sorted (6, 20, 22, 24, 25) . The mechanism of transfer between the cisternae, resulting in passage across the stack, is unknown but must be central for understanding the sorting of proteins that occurs in the Golgi complex . A major difficulty in elucidating the nature of intercisternal protein transport has been that these transfers occur between membrane compartments that are physically attached and not easily separated: In general, transport processes can only be studied effectively when compartments that provide and receive the transferred substrate can tein (G protein) largely containing trimmed (mannoses)-oligosaccharide chains, a pool believed to reside in Golgi membranes (11) .
In this article we provide a further demonstration that the transferred G protein can originate in the Golgi complex, and locate one such source within this organelle more precisely. We show that G protein that has just received peripheral Nacetylglucosamine (GIcNAc) in one Golgi complex is readily transferred to another Golgi complex to receive galactose (Gal); moments later, having received Gal in the original Golgi complex, the same G-protein molecule is poorly transferred, if at all. The differential fate of G protein, depending upon its location within the Golgi complex at the time of fusion, offers new insights into the compartmental organization and the nature of intercompartmental transport in the Golgi stack .
MATERIALS AND METHODS
Proteins and Enzymes : Neuraminidase from C. perfringenswastype X from Sigma Chemical Co. (St . Louis, MO) and was dissolved at a concentration of 100 U/ml in 50 mM sodium citrate buffer (pH 5 .3) and stored at -20°i n aliquots . Ricinus communis agglutinin I (ricin, RCA 120) was from Vector Laboratories, Inc . (Burlingame, CA) and came dissolved in 10 mM phosphate buffer (pH 7 .1), 0 .9% NaCl, 0 .04% NaN3 at 5 mg/ml. Wheat germ agglutium (Vector Laboratories, Inc.) was dissolved at 10 mg/ml in 0 . l s M NaCl, 10 mM HEPES pH 7.4, 0.02% NaN 3. Pronase was from Calbiochem-Behring Corp.
(San Diego, CA), and fetuin from Gibco Laboratories, Grand Island Biological Co . (Grand Island, NY) . Slug lectin (Limaxfavus agglutinin; LFA) was purified as described earlier (15) , lyophilized from 0.1 M NaCI-50 mM Tris-HCI (pH 7 .5), dissolved in one-fifth the original volume of water, dialyzed into 0 .1 M NaCI-50 mM Tris-HCI (pH 7 .5), frozen in liquid nitrogen, and stored in aliquots at -80°C. The final protein concentration was 3 mg/ml .
Cell Lines : Chinese hamster ovary (CHO) clones 13, 15B, and 1021 were kindly provided by Stuart Kornfeld (Washington University, St. Louis, MO) . The CHO mutant Lec2 and its wild-type parent W5 were generously provided by Pamela Stanley (Albert Einstein College of Medicine, Bronx, NY) . All were grown in monolayer in Eagle's minimum essential medium as described (21) .
Preparation of Mixed Monolayers: These were formed by exactly the procedures described in the preceding article (21) , except the CHO cell lines employed were different. For one set of experiments, the infected cells were of clone 13 and the uninfected cells were of clone 15B . For the other, the infected cells were of clone 1021 and the uninfected cells were again of clone 15B .
Labeling and Fusion of Mixed Monolayers: Mixed monolayers (6 cm) were rinsed with warm Tris-saline medium (21) plus 15 mM NH.Cl, and then treated with 2 ml of a cycloheximide-containing medium for 7 min before a 3-min pulse-label of D- [6' H]glucosamine (GlcNH2 ) (20 Ci/mmol) or D-[ I 'H]galactose (Gal) (11 Ci/mmol ; (both from New England Nuclear, Boston, MA) in the presence of cycloheximide. Both of these steps employed the low-bicarbonate minimum essential medium described (reference 21, footnote 4), but containing 10% of the usual glucose (0.1 g/liter) and supplemented with 7% dialyzed fetal calf serum, 15 mM NH.Cl, and 100 ug/ml cycloheximide . For the pulse-labeling, 1 .5 ml per plate of this low-glucose medium containing 1 mCi/ml of the appropriate 'H-sugar was used . This labeling medium was saved for repeated use, and was centrifuged (2,000 g for 2 min) in between each occasion to remove cellular debris.
After the 3-min pulse, a variable period of chase was carried out before fusion. Labeling medium was immediately replaced with 2 ml of a chase medium ; this was growth medium supplemented with 100 ug/ml cycloheximide, 15 mM NH,Cl, 15 mM HEPES, pH 7.4, and either 5 mM GicNH 2 (when only ['H]GIcNH2 was used in the experiment) or 2 .5 mM GIcNH2 and 2 .5 mM Gal (when both 'H-sugars were used in the same experiment) . When no period of chase was required before fusion, the plate was simply rinsed with the chase medium and then fused .
To fuse the mixed monolayer, the chase medium was aspirated and immediately replaced with 2 ml of warm pH 5 fusion medium (reference 21, footnote 3) containing 15 mM NH< Cl and 100 jug/ml cycloheximide. After 1 min at 37°C, this medium was replaced with 4 ml of chase medium . Unless otherwise specified, after a further 1-h incubation to allow inter-Golgi transport and glycosylation, the monolayer was harvested for analysis . Every plate was examined by light microscopy within 10 min after fusion to confirm that extensive fusion had in fact occurred.
Purification of Protein from Mixed Monolayers by Immunoprecipitation and SDS-Gel Electrophoresis : The cells were solubilized in a 0.5-ml vol and all of this used for immunoprecipitation with anti-G serum onto Staphylococcus aureus cells as described in the preceding paper (21) for the ['H]paimitate experiments . Then, the washed S. aureus cell pellet was suspended with 75 ul of SDS-gel electrophoresis sample buffer (13) and boiled . The supernatant was combined with 20 yl of sample buffer containing a 1 :1 mixture of ["S]methionine (Met}labeled VSV virions grown on clone 13 and on wild-type CHO cells, -8,000 cpm of "S in total protein . These samples were then electrophoresed in alternate lanes (to prevent their cross-contamination) of 10% polyacrylamide gels (13) , which were then fixed for 2 h in 25% (vol/vol) isopropanol, with one change of fixative . After a 5-min rinse with water, the gels were dried onto Whatman 3 MM paper (Whatman Chemical Separation Inc., Clifton, NJ) and autoradiographed for 3 d . The 'S S-labeled VSV enabled the G-protein band to be located by autoradiography . In that the mobility of G varies with the extent of its glycosylation, a mixture of "S-G protein (from clone 13 and wild-type CHO cells) that would bracket the entire mobility range of 'H-G proteins was co-electrophoresed. The resulting double band of "S-G protein was located in each lane of the dried gel and cut out together with an extra 2 mm above and below it. The remainder of the gel was reexposed to x-ray film to confirm that all of the G-protein region had been excised .
Preparation of Glycopeptides from Purified G Protein : The excised portions of dried gel containing G protein were swollen for --15 min in 0.1 M ammonium bicarbonate containing I mM CaC12 and 0 .02% NaN3. Pieces of gel, separated from the paper support, were chopped with a razor blade into -1 mm' fragments. To digest G protein in situ, the gel pieces were vigorously shaken with 0.5 ml of I mg/ml pronase in the bicarbonate buffer in a tightly sealed tube for 1 d at 50°C. (The pronase solution used had been previously heat-treated for 1 h at 50°C.) The aqueous phase, containing released peptides and glycopeptides, was saved and the gel pieces further incubated with another 0 .9 ml of pronase solution for another day at 50°C . The combined digests were centrifuged to remove debris, and the supernatant was lyophilized, dissolved in 0 .5 ml water, centrifuged again, and lyophilized again, and finally the residue was dissolved in 60 ul of 0.1 M Tris-HCI (pH 7 .5), 10 mM EGTA, 0.02% NaN3 , and boiled for 3 min to inactivate any remaining pronase. The resulting concentration of free Ca" was calculated to be 13 mM (above the EGTA concentration). This glycopeptide preparation was used directly for binding to slug lectin (i.e., for experiments with clone 1021 mixed monolayers) . When binding to ricin was to be measured (i.e., when clone 13 was used), terminal sialic acid residues were first removed . To accomplish this, the entire glycopeptide preparation was incubated with 2 ul of 100 U/ml neuraminidase for -16 h at 37°C, and then boiled. Control experiments established that this treatment quantitatively removes sialic acid but does not release any Gal or GIcNAc (data not shown). The overall recovery of 'H for all of the steps in going from immunoprecipitate to the glycopeptide preparation averaged 70% . The ' SS/'H ratio in the preparations was in the range of 0 .5-1 .
Binding of Glycopeptides from Fusion Experiments to Lectins for Analysis: To assay the percent of the glycopeptide able to bind to ricin (1), 20-ul samples of each neuraminidase-digested glycopeptide preparation were incubated with 40 ul of ricin (5 mg/ml) for 15 min at 25°C, in duplicate. Afterwards, each incubation was mixed with 1 ml of ice-cold 4 M (NH4)2SO4 (dissolved in 50 mM Tris and titrated to pH 7) containing 0 .01 % bovine serum albumin (added from a I % solution) . After centrifugation for 15 min in a microfuge in the cold, the pellet was resuspended in 1 ml of the icecold buffered 4 M (NH 4) 2 SO4 solution (not containing albumin) and centrifuged for 15 min. The washed pellet was dissolved in 1 .5 ml of water and counted for 'H (representing glycopeptide), correcting for the trace of "S-peptides present in the lectin precipitate . The duplicates agreed to within 5% . The total amount of 'H in the glycopeptide preparation was measured by counting a 10-ul sample, correcting for the "S present . All of the 'H in the preparations was in glycopeptides because 'H was quantitatively precipitated by 40 ul of wheat germ agglutinin (10 mg/ml) when this lectin was used in place of ricin (data not shown). The percentage of 'H-glycopeptide binding to ricin was then calculated. This quantity, being an internal ratio, is independent of variations from monolayer to monolayer in the yield of G protein and its glycopeptides.
Binding to slug lectin was assayed identically, using 40 ul of 3 mg/ml slug lectin, except the wash with albumin-free ammonium sulfate was omitted .
Preparation of Viral Particles and Glycopeptide Markers : To prepare "S-labeled virions, a confluent l0-cm plate of the desired cell type was infected with VSV at -5 plaque-forming units/cell . At 3 h postinfection, 100 MCi of ["S]Met per plate was added in 4 ml of Met-free minimum essential medium (21) containing 7% dialyzed fetal calf serum . After 3 h, the medium was clarified by centrifugation at 2,000 g for 10 min, and this supernatant was layered onto a cushion of 20 (wt/vol)% sucrose in 1 mM Na2EDTA, 10 mM Tris-HCI (pH 7.4) and centrifuged in the SW50 .1 rotor for I h at 50,000 rpm, and the viral pellet thus obtained .
To prepare virions in which G protein was labeled with isotopic sugars, a confluent 10-cm plate of the desired cell type was infected and 3 h later the monolayer was rinsed with Tris-saline medium (21) and 2.5 ml of low-glucose medium containing 200 ACi of'H-sugar (either GlcNH2 or Gal) or 50 ACi of [l°ClGal (New England Nuclear, uniformly labeled) was added. Low-glucose medium had the composition of Met-free minimum essential medium (reference 21, footnote 2) but contained glucose (0 .1 g/liter), had 0.25 mM Met, and was supplemented with 7% dialyzed fetal calf serum and 15 mM HEPES (pH 7.4). After 2 h virions were prepared as above. SDS-gel electrophoresis (data not shown) confirmed that G was the only radioactive protein in these preparations.
To prepare labeled-VSV glycopeptides for use in testing the specificity of lectin precipitation assays (see Figs. 2 and 8) , the viral pellet was boiled in 200 g1 of 1 % SDS, 15 mM dithiothreitol, 50 mM Tris-HCl (pH 6.8)and precipitated by adding 20 A1 of 2% Triton X-100 as carrier and then 200 ul of cold 20% trichloroacetic acid . The precipitate was collected by centrifugation for 5 min in a microfuge, washed once with ice-cold acetone (0 .3 ml), and air-dried. Then, 100 pl of a freshly prepared pronase solution (20 mg/ml in 0.1 M Tris-HCI pH 7.5, 10 mM CaC12, with 1 drop of toluene per ml) was added. After 1 d at 50°C, the digest was sonicated for 30 s using a water-bath sonicator, and another 100 pl of pronase solution was added. After another day at 50°C, the digest was boiled and stored at -20°C. The precipitates that formed upon thawing were removed by centrifugation before use and contained no radioactivity . 50-90% of the total radioactivity in these preparations was in glycopeptide, as judged by the percentage that could be precipitated by saturating levels of wheat germ agglutinin (data not shown). The remainder is presumably due to contaminating sugar precursors.
RESULTS

Transfer of G Protein between Golgi Complexes after Cell Fusion
To ascertain whether G protein present in the Golgi complex of one cell can move to the Golgi complex of another after fusion, mixed monolayers were formed by the procedure of the preceding paper (21) . These consisted of VSV-infected CHO clone 13 cells and uninfected CHO clone 15B cells (schematized in Fig. 1 ). Clone 13 is a mutant line that is defective in glycosylation but apparently not in intracellular transport (2) . Specifically, G protein synthesized in clone 13 cells will acquire G1cNAc termini in the Golgi complex, but will lack Gal and sialic acid residues. The idea (Fig. 1) is to label G protein via ['H]G1cNAc in the Golgi complex of infected clone 13 cells, and then to fuse these cells to an uninfected cell population whose Golgi complex is capable of adding Gal residues. The question is, can G protein, labeled in its GIcNAc residues in the clone 13 Golgi complex, be transported to another Golgi population where it will be further glycosylated with Gal and possibly other sugars? The preceding paper (21) shows that two Golgi populations derived from two types of CHO cells remain distinct after cell fusion.
For the uninfected cell population, whose Golgi complex acts to galactosylate G protein in the experiment, we have chosen CHO clone 15B. This cell line is specifically missing G1cNAc transferase 1 (14) and so is unable to initiate the branch in the asparaginyl-linked oligosaccharide processing pathway that leads to the synthesis of complex-type oligosaccharides containing peripheral G1cNAc, Gal, and sialic acid (11) . However, the Golgi complex of 15B cells should be able to complete the synthesis of a complex chain by adding additional G1cNAc, Gal, and sialic acid ifG1cNAc transferase I has already acted. We have used clone 15B cells (rather than wild-type cells) as the uninfected acceptor population to minimize the incorporation of ['H]G1cNAc into glycoproteins in these cells . This choice greatly lowers the background in immunoprecipitations, facilitating the analysis of the ['H]-G1cNAc incorporated into G protein in the other minor cell population (clone 13) that is infected.
Briefly, the protocol for the experiment is to pulse-label the mixed monolayer with ['H]G1cNH 2 for 3 min, and then to fuse the cells by exposing them to a pH of 5 for 1 min. Monolayers are then incubated in a chase medium to prevent further incorporation of 'H, and stopped at various times to determine what fraction of the G protein labeled with ['H]-G1cNAc while in the clone 13 Golgi complex had gone on to receive Gal in the clone 15B Golgi .
The pulse of ['H]G1cNH2 is added after a 7-min pretreatment with cycloheximide, and this drug is maintained in the media used thereafter. Cycloheximide, which does not affect intracellular protein transport (16) , serves two essential purposes . First, it prevents the co-translational incorporation of ['H]GlcNH2 (via the dolichol-linked oligosaccharide) into the pair of G1cNAc residues in the inner core of the G-protein oligosaccharide. This ensures that all 'H is incorporated into G in the Golgi complex, none in the endoplasmic reticulum . Second, cycloheximide greatly improves the efficiency of the chase . In CHO cells, G protein takes -10 min to be transported to the Golgi complex after protein synthesis in the endoplasmic reticulum (7), so very little G protein remains available as potential substrate for incorporation of ['H]-G1cNAc after a 7-min treatment with cycloheximide and a 3-min pulse label.
To measure the addition of Gal to ['H]G1cNAc-labeled G protein, G protein was immunoprecipitated from detergent extracts of the mixed monolayers and further purified by SDS-gel electrophoresis, and glycopeptides were prepared by exhaustive digestion with pronase . All of the 'H at this stage was derived from G protein, as mock-infected monolayers had no detectable 'H in the glycopeptide fraction (data not shown) . The fraction of these 'H-glycopeptides that were able to bind to ricin, a lectin specific for Gal, was then determined . Following essentially the procedure of Baenziger and Fiete (1), the G-protein glycopeptides were incubated with excess ricin, and the bound ['H]GIcNAc-labeled glycopeptides were precipitated (together with ricin) by ammonium sulphate and counted . Only those glycopeptides from G-protein molecules that had received ['H]GIcNAc in the clone 13 Golgi complex and then Gal in the clone 15B Golgi complex would score in this assay. Fig. 2 demonstrates that the specificity of the ricin-binding assay for Gal-containing glycopeptides is as expected (1) . The glycopeptides ofG protein synthesized in wild-type CHO cells (terminating in Gal and Gal-sialic acid) bind to ricin (0) but the G protein glycopeptides made in clone 13 cells (terminating in GIcNAc) do not (A). The G-protein glycopeptides made in a mutant unable to add sialic acid (terminating exclusively in Gal) binds even more efficiently than the wild-type glycopeptide (O). Therefore, the VSV G glycopeptides from fusion experiments were routinely digested with neuraminidase before the ricin-binding assay. cpm) and varying amounts of ricin agglutinin I (5 mg/ml) . Bound glycopeptide was precipitated with 4 M ammonium sulfate containing serum albumin carrier and washed once, and counted as described in Materials and Methods . Parallel incubations with saturating amounts of wheat germ agglutinin (able to bind all three forms of VSV glycopeptide) were carried out to determine what fraction of the total 'H was present as glycopeptide . For this purpose, glycopeptide (2 pl) was incubated with between 2 and 5 al of 10 mg/ml wheat germ agglutinin and processed as above . Shown is the ratio of 'H precipitated by ricin to that precipitated by wheat germ agglutinin, expressed as percent . Table I offers a summary of data on the extent of interGolgi transport measured by the extent of galactosylation at 1 h after fusion, when this process had gone to completion. In two independent experiments (line A) 32 ± 9% (SD) and 25 ± 3% of ['H]G1cNAc-labeled G protein received Gal . The difference between the experiments is due to a small but systematic difference in the composition ofmixed monolayers (i.e., the ratio of the two types of Golgi) between experiments. This difference can be corrected for by employing a "prefusion" control (line D) in which the monolayer is fused first and then, 30 min later, labeled with ['H]GIcNHZ, chased for 1 h, and then analyzed. This prefusion protocol enables G protein to completely randomize among the two Golgi populations before labeling, providing an internal standard that measures the maximum amount of galactosylation that can occur given the ratio of the two cell types in the mixed monolayers used. It is this value that would result if all ofthe G protein labeled before fusion were totally randomized among Golgi complexes after fusion . Prefusion gave 60% and 51 % galactosylation, respectively, for Expts. I and II. The ratio of the extent of galactosylation after fusion (line A) to the prefusion control (line D) then measures the fraction of ['H]GIcNAc-labeled G protein present in clone 13 cells before fusion that becomes randomized among the total Golgi population after fusion, and was very similar for the two experiments (0.53 vs. 0.49). Indeed, the overall efficiency of interGolgi transfer, resulting in -50% randomization, is striking. As pointed out in the Discussion section, even this is an underestimate due to intercompartmental transfer occurring during the pulse and before fusion, the actual efficiency of ROTHMAN randomization among Golgi complexes being closer to 100%. When the fusion step (the pH 5 treatment) was omitted, very little galactosylation (-5%) occurred (line B). When uninfected clone 13 cells replaced clone 15B cells in the fused mixed monolayers (line C), a similarly low level of galactosylation resulted. Together, these controls show that fusion to a complementing mutant is necessary for the galactosylation to occur, and that neither the act of fusion nor the pH 5 treatment somehow correct the defect in clone 13 cells . The low level of addition of Gal in clone 13 may reflect some leakiness in this mutation.
The rapidity and efficiency with which G protein is transported between two Golgi populations after cell fusion (Fig.  3 ) prompted us to examine the kinetics of the corresponding process of transport within a single Golgi population in unfused cells, and also to see whether the act of fusion has any effect on this rate.
For this purpose we have used homogeneous monolayers of VSV-infected CHO clone 1021 cells. Clone 1021 is a line that will incorporate G1cNAc and Gal into proteins transported through its Golgi complex, but will not add sialic acid (2) . Monolayers were pulse-labeled with [3H]G1cNH 2 after cycloheximide pretreatment and harvested after varying periods of chase.
The percentage of [3 H]G1cNAc-labeled G protein terminating in Gal as a function of the time of chase was measured by the ricin binding of the glycopeptides (Fig. 4a) . This process occurred with a half-time of -5 min. These kinetics (Fig. 4a) , within a single Golgi complex or population of Golgi complexes, are virtually superimposable upon those for the same transport segment purposefully measured between two Golgi populations (Fig. 3) , apart from the initial lag of -5 min (the time required for fusion) in the latter case.
The similarity of these rates makes it plausible to consider that the inter-Golgi transfers detected upon fusion of mixed 
no significant effect upon the kinetics of addition of Gal after the incorporation ofGIcNAc in the Golgi . Fig. 46 shows the kinetics for this process when measured in cells that have already been fused, and Fig. 4c shows the kinetics in cells in the process of fusing . The dashed line shows the kinetics for the unfused cells, redrawn from Fig. 4a for comparison . The poor agreement between the replicate plates in Fig. 4 c at the early time points (the bars show 1 SD about the mean) is due to the variability in the time needed for the manipulations required to fuse the cells in between the pulse and the chase. A potential complication in the interpretation of these experiments arises from the use of NH4CI to prevent the infection ofone of the cell populations in mixed monolayers. It was therefore important to ascertain whether or not NH4CI, under our experimental conditions, has a quantitatively significant effect on the transport of VSV G protein. Fig. 5 a shows that the overall rate of intracellular transport of G protein-the kinetics of appearance in virions of G protein labeled in the rough endoplasmic reticulum with ['SS]Metis not affected by 15 mM NH4CI. Similarly, the rate of the particular transport segment upon which this study is focused-the movement of G protein for the site of GIcNAc addition to the site of Gal addition in the Golgi complex-is not affected by NH4CI (Fig. 5 b) . All of the experiments in Fig. 4 were carried out in the absence of NH4CI. (a) Lack of effect of ammonium chloride on the kinetics of transport of G protein from rough endoplasmic reticulum to budded virions . Confluent 6-cm monolayers of VSV-infected CHO clone 1021 cells were pulse-labeled with 25 uCi per plate of ["S]-Met in 2 ml of Met-free MEM for 10 min, starting at 3 h postinfection . Then, a variable period of chase in growth medium plus 2 .5 mM unlabeled Met was begun . At the appropriate time, the medium was removed from a plate and virions pelleted as described in Materials and Methods . The pellet was dissolved in sample buffer, electrophoresed in a 10% polyacrylamide SDS gel which was dried and autoradiographed . The relative amounts of "S-labeled G protein in the pellets were then determined as the area under the G band by densitometry of the X-ray film . Two such experiments were conducted in parallel . In one (") no NH 4 CI was present at any stage, as just outlined . In the other (p), 15 mM NH 4 CI was added at 1 h postinfection and maintained at every stage thereafter . Plotted is the amount of 35 S-G protein in the viral pellet as a function of the time of chase at which the medium was harvested, expressed as a percent of the value obtained for the NH 4CI-free experiment at 2-h chase . The amount of "S-G protein synthesized in the 10 min pulse was the same with and without NH 4 CI (data not shown) . 
Availability of G protein for Transfer Depends upon Its Location in the Golgi Complex at the Time of Fusion
Experiments presented in the preceding article (21) show that freshly acylated G protein, pulse-labeled with ['H]palmitate just before fusion, will transfer to an exogenous Golgi population (to receive peripheral GIcNAc). But, when a period of chase is allowed to permit further transport before cell fusion, G protein rapidly becomes unavailable for this same transfer, with a half time of -5 min.
A very similar result is obtained when a period of chase separates the labeling of G protein with ['H]G1cNAc (in the Golgi complex of clone 13 cell) and fusion (Fig. 6) . The fraction of ['H]GIcNAc-labeled G protein that eventually reaches the 15B Golgi complex to receive Gal falls precipitously as the period of transport before fusion is increased, declining with a half time of~5 min .
There are two general kinds ofexplanations for these kinds ofbehaviors . On the one hand, G protein could be transported during the chase into a new location in the cell from which it does not transfer after cell fusion; the time course (Fig. 6) would then measure the rate of its entry into this new compartment. Alternatively, G protein might stay in the same physical location during this brief period of chase but be modified or associated with other component(s) so as to prevent its transfer. The latter kind of possibility seems to be ruled out because during this same period after the addition ofGIcNAc in the Golgi complex, G protein can movebetween Golgi complexes (Fig. 3) and therefore is undergoing transfers to new locations .
Given that G protein is relocating during the time course in Fig. 6 , where is it going to? On the one hand, G protein could be leaving the Golgi complex entirely, on its way to the plasma membrane (which would readily explain why this pool of G protein would not reenter a second Golgi population after fusion) . On the other hand, G protein could be entering a new and later compartment within the Golgí complex. Given that ['H]GIcNAc-labeled G protein becomes unavailable for transfer (Fig. 6) , with the same kinetics that it normally receives Gal (Figs. 3 and 4 would seem likely that the compartment it is entering is still within the Golgi complex . Indeed, the simplest possibility would be that GIcNAc and Gal are added in distinct and sequential compartments in the Golgi complex, between which G protein is transported unidirectionally. Transfer between these compartments would normally occur by a dissociative process, which in our experiments is detected as transfers between the two compartments residing in different Golgi populations. Once the intercompartmental transfer has already occurred (before fusion), it could not take place again (after fusion).
Compartmental Specificity of the Transfer Process
This hypothesis makes a strong prediction. G protein, freshly labeled with ['H]GIcNAc in the earlier (GIcNAc) Golgi compartment, should be efficiently transferred to the later (Gal) compartment ofa second Golgi population after fusion. But G protein already within the later (Gal) compartment, freshly labeled with ['H] Gal, should be poorly transferred to the same sites after fusion.
To test this, we have constructed mixed monolayers consisting ofVSV-infected CHO clone 1021 cells and uninfected clone 15B cells (Fig. 7) . Clone 1021 will add both GIcNAc and Gal to G protein in its Golgi complex, but will not incorporate sialic acid (2 Design of a cell fusion experiment to measure the relative efficiency with which G protein present in two different Golgi complex subcompartments (in which GIcNAc and Gal, respectively, are added) is transferred to an exogenous Golgi population . A mixed monolayer is formed containing VSV-infected CHO clone 1021 cells and uninfected clone 15B cells. VSV G protein is labeled in the Golgi complex of clone 1021 cells either with ['H]GIcNH 2 (incorporated as peripheral GIcNAc) or with ['H]Gal . Clone 1021 is able to incorporate both of these sugars, but not sialic acid . The clone 1021 cells, now harboring 'H-G protein in their Golgi complexes, are then fused to neighboring clone 15B cells (via a brief exposure to pH 5) whose Golgi complex are able to add sialic acid . Transfer of G protein from the clone 1021 to the clone 15B Golgi complex is monitored by the addition of sialic acid to the 'H-G protein upon arrival . In the case of the ['H]GIcNAc-labeled G protein, the addition of Gal (presumably in the 15B Golgi complex) must occur before sialic acid can be added .
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THE JOURNAL OF CELL BIOLOGY -VOLUME 99, 1984 efficiencies . This transfer can be monitored by the incorporation ofsialic acid that occurs after arrival (G protein labeled with ['H]G1cNAc would also have to receive Gal in the 15B Golgi complex).
To assay the addition of sialic acid to ['H]GIcNAc-and ['H]Gal-labeled G protein, the G protein was purified from detergent extracts of fused monolayers by immunoprecipitation and SDS-gel electrophoresis, and pronase glycopeptides were prepared as before. To distinguish those glycopeptides that contained terminal sialic acid, we employed the recently described (15) Limax flavus agglutinin . This slug lectin is specific for sialic acid (15) , and like ricin we have found that it can be used in a binding assay, in which complexes of sialylated glycopeptides with slug lectin are separated from unbound glycopeptide by an ammonium sulfate precipitation . Fig. 8 demonstrates the specificity of the slug lectin binding assay for sialic acid-containing VSV G protein glycopeptides.
A maximum of -30% of the sialylated glycopeptides made in wild-type CHO cells is bound. Binding is prevented by competition with excess fetuin, is abolished by neuraminidase digestion, and is not detectable when Gal-terminating VSV G protein glycopeptides (made in a mutant CHO cell unable to add sialic acid) are used as substrate .
Microheterogeneity in sialic acid combined with a strong preference of slug lectin for glycopeptides containing two or more sialic acid residues accounts for the relatively small fraction of wild-type glycopeptide that are bound. This is illustrated in Fig. 9 , which presents a gel filtration analysis of the total VSV G glycopeptides made in wild-type CHO cells (labeled with 'H, 0) and ofthe subfraction that can be bound to slug lectin (labeled with I4C, O) . The Bio-Gel P-4 column separates VSV glycopeptides principally according to the 5 10 15 SLUG LECTIN ADDED (jig) FIGURE 8 Specificity of slug lectin (Limax flavus agglutinin) for sialic acid-containing VSV glycopeptides . Pronase glycopeptide markers were prepared from ['H]GIcNH2 -labeled G protein synthesized in a wild-type line of CHO cells, W5 ("), and a mutant isolated from this line that is unable to incorporate sialic acid but will incorporate Gal, Lec2 (A) . Incubations for 15 min at 25°C contained 2 jAI of glycopeptide (about 1,000 cpm) and the indicated amounts of slug lectin (0.8 mg/ml in 0 .1 M NaCl, 50 mM Tris-HCI [pH 7.5], 0 .02% NaN,) . In one case (A), neuraminidase-digested wild-type glycopeptide was used (prepared by adding to the pronase digest 10 u/ ml of neuraminidase and incubating for 16 h at 37°C, then boiling) . In another case (O), intact wild-type glycopeptide was used but fetuin (7 mg/ml final concentration) was also added . Bound glycopeptide was precipitated with 4 M (NH 4 )2 SO4 containing albumin, washed once, and counted as described in Materials and Methods for ricin binding. Parallel incubations of each glycopeptide preparation were carried out with wheat germ agglutinin and processed exactly as described in Fig. 2 to precipitate all of the 'H-glycopeptide present . Shown is the ratio of 'H precipitated by slug lectin to that precipitated by wheat germ agglutinin, expressed as percent . number of sialic acid residues that they contain (12) resulting in four major peaks labeled So, S,, S2, and S3 in Fig. 9,  containing 0, 1, 2 , and 3 sialic acids per oligosaccharide chain, respectively. (The double peak ofSo is probably due to microheterogeneity in fucose; it is not related to sialic acid because the profile of clone 1021 VSV glycopeptides consists of a double So peak and no S,, S2, or S3.) The glycopeptides from CHO cells consist of So, S,, and S2, with very little S3. However, the slug lectin precipitate consists almost exclusively of S2 and S3, with only a trace ofS, and no So. Table II Separation of the glycopeptides that bind to slug lectin according to the number of sialic acid residues they contain, by gel filtration on Bio-Gel P-4 . The slug lectin precipitate from "C-labeled glycopeptide (O) was co-chromatographed with total 'H-glycopeptides (9) . For this purpose, 10 ul of ["C]Gal-labeled VSV glycopeptides (containing 1,100 cpm) synthesized in a wild-type line of CHO cells (W5) were incubated with 50 ul of slug lectin (0 .8 mg/ml), precipitated with ammonium sulfate containing albumin, and washed with ammonium sulfate as in Materials and Methods . The precipitate was dissolved in 100 tel of 1% SDS-1% ß-mercaptoethanol, boiled, and mixed with 10 ul of ['H]GIcNAc-labeled VSV glycopeptides (containing 2,500 cpm) prepared from infected W5 CHO cells, and 90 pl of 33 mM EGTA-18 mg/ml bovine serum albumin-110 mM Galactose . This sample was loaded onto an 1-x-105-cm column of -80 ml bed volume of Bio-Gel P-4 (minus 400-mesh, Bio-Rad) that was equilibrated and eluted with 20 mM sodium phosphate buffer (pH 7 .0) containing 0.5 mM NaN 3 , using gravity flow . Fractions of 0 .6 ml were collected and counted for 10 min to measure "C (O) and 'H (0) . The void volume, fraction 41, was determined as the peak fraction in which albumin eluted . The total included volume, judged by the elution of free [' 4C ]Gal, was in fraction 132 . Only the fractions containing glycopeptides are shown . The positions of VSV glycopeptides containing 0, 1, 2, and 3 sialic acid residues ($o, S,, S Z , and S3 , respectively) were located by reference to glycopeptides from VSV-infected baby hamster kidney cells (in which S3 is a major species [12, 17] ) and CHO 1021 cells (in which So is the only significant species due to the lack of sialic acid addition) . Note that the sialic acid-free species (So) chromatographs as a double peak . This is also true of the 1021 cell VSV glycopeptide marker (not shown), and probably represents unsialylated species having or lacking a fucose residue .
which uninfected clone 1021 cells replaced the uninfected clone 15B cells in the formation of the mixed monolayers, 0.8 ± 0.3% (line E). This represents the background level of sialylation in the clone 1021 mutant cells. To rule out the possibility that any 'H in the slug lectin precipitates was present as [3H]sialic acid (derived by metabolism of [3H]-G1cNH2), glycopeptides were released from the precipitate by boiling and digested with neuraminidase . No 3H was released from the glycopeptides ; however, all of the sialic acid was released, as judged by the fact that the binding of the glycopeptides to slug lectin had been abolished (data not shown).
It is particularly important to recognize that in these fusion experiments only a fraction (roughly one-third) of the Gprotein molecules (Figs. 8 and 9 ) transported will actually be scored in the slug lectin-binding assay, due to the microheterogeneity of the sialylation process and the requirement of multiple sialylation for binding . This factor accounts for the apparently low numbers in Table 11 as contrasted to Table 1 . In fact, the actual efficiency oftransfer of[3H]GIcNAc-labeled G protein is very similar in the two types of fusion experiments. If only one-third of the transfers in Table II were scored in the slug-lectin assay employed, then -10% x 3 = 30% of [3H]GIcNAc-labeled G-protein molecules would have been transferred to the exogenous Golgi complex (to receive Gal and be incompletely sialylated). This is to be compared with the efficiency when Gal addition is directly measured in the clone 13 experiment,~28% (Table I , average of Expts. I and II). The prefusion experiment is also important in this regard. This control, in which the mixed monolayer is fused 30 min before labeling to enable G protein to randomize amongst the two Golgi populations, measures the maximum fraction of glycopeptide that could possibly be scored in the slug lectin-binding assay. This value was 32.3 ± 1.9% (Table  II, Fig. 10 together with the cumulative errors in the form of vertical bars. This fivefold difference in efficiency is also about that expected from the pulse-chase experiment in Fig. 6 , in which G protein labeled with ['H]G1cNAc (and moving toward the site in which Gal would be added) is 28% as efficiently transferred after 10 min of chase as at the outset .
Altogether, these experiments suggest that the population of G protein that is being transferred to exogenous Golgi complex is one that has received peripheral GIcNAc but has not yet received Gal. In that both of these sugars are added in the Golgi complex (11) , it seems clear that the transferred pool in between these two biochemical landmarks is in the Golgi complex as well.
The observed behavior also provides a clear internal control (in addition to the morphological ones presented in the preceding article) to indicate that the observed glycosylations result from transfer of G protein between two Golgi populations that remain distinct. As alternatives, had the two Golgi populations fused, or had the glycosylation defect in the G protein-containing Golgi population been corrected by any mechanism (such as replacement of the missing protein or transferase by material transferred from the 15B Golgi population, etc.), then the efficiency of sialic acid addition to [3H]-Gal-labeled G protein would have been the same or greater than that for [ 3H]GIcNAc-labeled G protein, the opposite of what is actually found . This is because the normal glycosylation pathway would be restored within the G protein-containing Golgí membranes by such mechanisms, and galactosylated G protein is the immediate substrate for sialylation . In each case, the percent of 3 H-G glycopeptídes receiving sialic acids due to fusion with clone 15B cells (i .e ., the increment in the percent of 3 H-glycopeptides bound to slug lectin due to fusion : 8.7 ± 0.7% for GIcNAc, 1 .8 ± 0.9% for Gal; data from Table II) was divided by the corresponding value for the prefusion control (30% ;  Table II ) and expressed as a percent. The error bars represent ±1 SD, calculated from the replicate determinations in Table II . The prefusion control in which G is allowed to randomize among the two Golgi populations before labeling measures the maximum amount of sialylation that can occur, and serves as an internal standard to gauge efficiency (see text). The properties of inter-Golgi complex transport in fused cells offer two new lines of evidence for a division of the Golgi complex into functionally distinct compartments . 2 First, G protein labeled with GIcNAc in one Golgi complex is efficiently transported to another to receive Gal residues . This inter-Golgi transport occurs at essentially the same rate as transit within the Golgi complex in a single cell . Therefore, a dissociative movement is required to carry G protein from the site at which GIcNAc is added to that in which Gal is added, implying that these two sugars are added in physically distinct parts of the Golgi complex.
Second, transport between these parts of the Golgi complex is vectorial, implying that a compartment boundary intervenes. This follows from the observation that once this transfer has already occurred before cell fusion, it cannot take place again after cell fusion . This, in turn, implies that the inter-Golgi complex transfer being studied after cell fusion also occurs before cell fusion-protein transport in the Golgi complex must normally be a dissociative process. In general, an irreversible step is needed to effect a vectorial process . The addition of Gal per se does not constitute the irreversible step, since the same behavior is observed in experiments with the clone 13 mutant in which Gal is not added.
Addition of Gal (and possibly sialic acid) occurs in the trans cisternae of the Golgi stack (9, 18, 19, 22, 26) . Presumably the compartment in which the GIcNAc is added consists of one or more earlier cisternae, but proof of this must await the immunocytochemical localization of GIcNAc transferases, now in progress.
How efficiently is G protein randomized among the Golgi populations during the intercompartmental transfer? About 50% (fraction galactosylated divided by prefusion control) of G protein labeled with ['H]G1cNAc in clone 13 Golgi before 2 Most of our knowledge of and concepts concerning subcellular compartments derive originally from electron microscopic studies which define compartments in morphological terms, as membranebound structures of distinct appearance . In general concept, a compartment is defined by the existence and properties of its boundaries. Therefore, a more widely applicable definition of subcellular compartments and one immediately pertinent to their molecular composition and their function in protein transport would be in terms of the selectivity of their boundaries. If a given molecule cannot move between two locations, or if it does so vectorially, then a compartment boundary can be said to exist to separate the two locations into distinct compartments. Such a boundary need not have an obvious morphological correlate. On the other hand, if a different molecule moves freely between these locations, then (from the point of view of this molecule) these two locations would be part of the same compartment or two copies of the same compartment. This definition encompasses the morphological concept of compartments, but also recognizes the complexity and specificity of biological transport processes by taking account of the possibility that the same compartment boundary can exist for, and be respected by, one type of molecule and be ignored by another. For example, each of several successive cisternae of the Golgi stack might contain different glycosyltransferases. So, boundaries would exist separating these cisternae into distinct compartments, and would be respected by these glycosyltransferases to prevent their intermixing . But a transported glycoprotein or a different set of glycosyltransferases might move randomly among these same cisternae. To such proteins, these cisternae would be indistinguishable and would represent multiple copies of a single compartment . same or another Golgi stack based on random encounter. This would happen unavoidably unless a special mechanism existed to prevent the budded vesicles from escaping. The rims of the Golgi complex are, of course, associated with numerous small vesicles.
Our experiments and their implications can help to distinguish between this kind of mechanism and several other widely discussed possibilities for protein transport in the Golgi stack (6, 20, 22, 25) diagrammed in Fig. 11 . Cisternal progression (Fig. 11 a) is a model in which new cisternae form at one end and are consumed at the other, and so the cisternae themselves move across the stack as intact units. In this scheme there are no transfers between cisternae ; hence, interGolgi protein transport would not be possible . Cisternal progression is also difficult to rationalize with the existence of compartment boundaries in the Golgi stack. Another proposal (Fig. 11 b) is that protein passes through the stack by lateral diffusion between transiently or permanently fused cisternae . Such fusions can occasionally be seen by electron microscopy, but it has not been clear whether they are real or, instead, fixation artifacts . Again, there are no dissociative transfers in the lateral diffusion scheme that would permit a facile interGolgi transport, and compartment boundaries would be hard to envision. Vesicular transport between the extensive apposing surfaces of adjacent cisternae (Fig. 11 c) would not allow escape from the stack to result in inter-Golgi transport. Therefore, the majority of intercisternal transfers are not likely to be en face.
The properties of inter-Golgi transport so far elucidated do not distinguish among many possible schemes for vesicular transport at the rim of the stack. At one extreme (Fig. 11 d) , each cisterns could be a distinct compartment whose boundaries are respected by proteins in transit. If so, each vesicular transfer step could be a vectorial one, and a protein would pass across the stack from one cisterns to the next, undirectionally. This scheme would allow only one chance for interGolgi movement with each intercompartmental transfer . At the other extreme (Fig. 11 e) transport could occur within a block of cisternae (comprising multiple copies of the same compartment) . Transit among these cisternae could proceed akin to a random walk. Such a scheme might allow many chances for inter-Golgi movement during a net passage across a stack .
In summary, the finding of a facile process for inter-Golgi transfer in CHO cells suggests a new view of the operation of the Golgi stack. The structure ofthe Golgi complex as a stack has led to the natural assumption that protein transport through it is processive; that is, a protein would necessarily progress in systematic fashion across a given stack. Our observations suggest the opposite. Protein transport in the Golgi stack is fundamentally a stochastic and dissociative process. Transport vesicles budding from cisternae dissociate, can 300°K (T), using the relation n = (kT1/3aRxz), where k is Boltzmann's constant . The answer is ,7 = 0.5 poise (-50 times the viscosity of water), meaning that the effective viscosity of cytoplasm would have to be at least this great for diffusion to become a limiting factor in inter-Golgi transfers. The effective viscosity of cytoplasm is not known and probably depends greatly on the cell type and on the size ofthe diffusing species, but current estimates are in the range of0.05-0.3 poise (27) from translational diffusion measurements in cytoplasm.
270 THE JOURNAL OF CELL BIOLOGY -VOLUME 99, 1984 Illustrations of several possible mechanisms for transport of protein and other macromolecules within the Golgi stack . (a) Cisternal progression . New cisterns form from vesicles at the cis face, the oldest cisterns at the trans face is consumed by shedding or vesiculation . As a result, the cisternae themselves move across the stack ; intercisternal transfers are not needed to effect transport across the stack . A vesicle budding from the rim of any given cisterns can fuse any other cisterns in a stochastic process governed only by a probability distribution . This kind of scheme would only require a small number of biochemically distinct transport systems, but many transfers would be required to traverse a stack. diffuse away, and are capable of fusing with the appropriate target present in the same or a different stack, based on a random encounter .
Why, then, does the Golgi complex need to exist as a stack? Our experiments suggest that protein transport in the Golgi complex could occur equally well if the compartments involved were separated and located at random. It may well be that, in many cells (but apparently not CHO cells), the cytoskeleton will so retard the vesicles that sufficiently rapid diffusion between the Golgi compartments would require their close proximity, as in a stack. In such instances, vesicles would still dissociate from the Golgi stack after their budding, but might be restrained from escaping by a meshwork of surrounding cytoskeleton, acting like a dialysis bag to keep the vesicles nearby .
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